Effect of dapagliflozin on uric acid in patients with chronic heart failure and hyperuricemia

Table 5 Adverse events and safety outcomes

Event	Dapagliflozin group (n = 100)	Placebo group (n = 100)	P value
Adverse events	64	62	0.83
Common adverse events
Infection	28	26	0.79
Hypotension	16	14	0.77
Renal impairment	12	10	0.73
Genital infection	10	2	0.01
Serious adverse events	20	22	0.79
Death	8	10	0.67